AMEDISYS INC (AMED) Stock Price, Forecast & Analysis
USA - NASDAQ:AMED - US0234361089 - Common Stock
AMED Key Statistics, Chart & Performance
The current stock price of AMED is 100.99 USD. In the past month the price increased by 3.61%. In the past year, price increased by 2.68%.
AMED Latest News, Press Relases and Analysis
AMED Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.45 | 99.45B | ||
| CI | THE CIGNA GROUP | 9.55 | 72.43B | ||
| LH | LABCORP HOLDINGS INC | 16.52 | 21.72B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.08 | 20.82B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 106.25 | 19.20B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.03B | ||
| DVA | DAVITA INC | 12.71 | 8.38B | ||
| HIMS | HIMS & HERS HEALTH INC | 65.89 | 8.04B | ||
| CHE | CHEMED CORP | 19.65 | 6.30B | ||
| RDNT | RADNET INC | 202.74 | 5.93B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 30.75 | 5.56B | ||
| OPCH | OPTION CARE HEALTH INC | 18.87 | 4.56B |
Related stock screener links
About AMED
Company Profile
Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 19,000 full-time employees. The company provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. The company owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia.
Company Info
AMEDISYS INC
3854 American Way, Suite A
Baton Rouge LOUISIANA 70816 US
CEO: Paul B. Kusserow
Employees: 19000
Phone: 12252922031
AMEDISYS INC / AMED FAQ
Can you describe the business of AMEDISYS INC?
Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 19,000 full-time employees. The company provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. The company owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia.
What is the current price of AMED stock?
The current stock price of AMED is 100.99 USD. The price increased by 0.01% in the last trading session.
What is the dividend status of AMEDISYS INC?
AMED does not pay a dividend.
What is the ChartMill rating of AMEDISYS INC stock?
AMED has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the PE ratio for AMED stock?
The PE ratio for AMEDISYS INC (AMED) is 21.26. This is based on the reported non-GAAP earnings per share of 4.75 and the current share price of 100.99 USD.
Can you provide the growth outlook for AMEDISYS INC?
The Revenue of AMEDISYS INC (AMED) is expected to grow by 4.17% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for AMEDISYS INC?
AMEDISYS INC (AMED) has a market capitalization of 3.32B USD. This makes AMED a Mid Cap stock.
AMED Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to AMED. When comparing the yearly performance of all stocks, AMED turns out to be only a medium performer in the overall market: it outperformed 48.13% of all stocks.
AMED Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AMED. While AMED has a great profitability rating, there are some minor concerns on its financial health.
AMED Financial Highlights
Over the last trailing twelve months AMED reported a non-GAAP Earnings per Share(EPS) of 4.75. The EPS increased by 11.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.56% | ||
| ROA | 3.87% | ||
| ROE | 6.95% | ||
| Debt/Equity | 0.26 |
AMED Forecast & Estimates
17 analysts have analysed AMED and the average price target is 102.87 USD. This implies a price increase of 1.87% is expected in the next year compared to the current price of 100.99.
For the next year, analysts expect an EPS growth of 13.17% and a revenue growth 4.17% for AMED